Humacyte Inc (HUMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,969 | -11,965 | -8,245 | 17,036 | -19,832 |
| Depreciation Amortization | 2,433 | 9,756 | 7,307 | 4,832 | 2,418 |
| Accounts receivable | 31 | 145 | 145 | -1,125 | -57 |
| Accounts payable and accrued liabilities | 299 | -509 | 984 | 374 | 934 |
| Other Working Capital | -159 | 1,029 | 3,109 | -376 | 391 |
| Other Operating Activity | 15,724 | -69,585 | -55,470 | -56,107 | -2,651 |
| Operating Cash Flow | $-18,641 | $-71,129 | $-52,170 | $-35,366 | $-18,797 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | 5,893 | 0 | 0 | N/A |
| PPE Investments | -1,152 | -1,048 | -367 | -156 | -22 |
| Investing Cash Flow | $-1,152 | $4,845 | $-367 | $-156 | $-22 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -528 | -1,981 | -1,463 | -957 | -462 |
| Common Stock Issued | 119 | 535 | 229 | 12 | 1 |
| Financing Cash Flow | $-409 | $-1,446 | $-1,234 | $-945 | $-461 |
| Beginning Cash Position | 149,772 | 217,502 | 217,502 | 217,502 | 217,502 |
| End Cash Position | 129,570 | 149,772 | 163,731 | 181,035 | 198,222 |
| Net Cash Flow | $-20,202 | $-67,730 | $-53,771 | $-36,467 | $-19,280 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,641 | -71,129 | -52,170 | -35,366 | -18,797 |
| Capital Expenditure | -1,152 | -1,048 | -367 | -156 | -22 |
| Free Cash Flow | -19,793 | -72,177 | -52,537 | -35,522 | -18,819 |